Question 18:
Christine is a 9-year-old female who presents for care after having been placed in
the local foster care system. She has been in and out of
... [Show More] foster care for the last 4
years after her parents were killed in an automobile accident. Christine has been
placed in a variety of homes and residential care facilities. The PMHNP recognizes
that Christine is at high risk for:
A. Dissociative disorders
B. Post-traumatic stress disorder
C. Impulse-control disorder
D. Attachment disorder
Question 7:
Caylee is a 5-year-old girl who is referred for evaluation by child protective services.
She was recently removed from her biological family and placed in foster care, as
her home environment was reportedly unsafe due to conditions of extreme neglect.
Her foster mother reports that Caylee is very quiet and withdrawn and always
appears sad and disinterested in her surroundings; however, she becomes very
irritable when anything unexpected or unplanned occurs. The foster mother became
very concerned when it appeared that Caylee was hallucinating. The PMHNP
considers that:
A. Caylee is at high risk for suicide and precautions should be taken
B. The hallucinations are consistent with brief psychotic disorder or schizophrenia
C. The history and reported symptoms are typical of depressive disorder in young
children
D. This is a common situation when prepubertal children are removed from the
biological parents regardless of how dysfunctional they are
Question 2:
Debi is a 15-year-old girl who is currently being treated for depression. Her parents
have been very proactive and involved in her care, and Debi has achieved remission
2 months after beginning treatment with a combination of pharmacotherapy and
cognitive behavioral therapy. While counseling Debi's parents about important issues
in management, the PMHNP advises that:
A. There is a > 50% likelihood that Debi's younger sibling will develop depressive
symptoms
B. The mean length of major depressive episode in adolescents is 4 months
C. 20 to 40% of adolescents who have major depressive disorder will develop bipolar
I within 5 years
D. Adolescent-onset depression typically need long-term pharmacologic
management to prevent relapses
Agomelatine
Brand: Valdoxan
-Melatonin multimodal (Mel-MM)
-Agonist at melatonergic 1 and melatonergic 2 receptors
-Antagonist at 5HT2C receptors
-Not FDA approved: Rx for Depression, Generalized anxiety disorder
-Initial 25 mg/day at bedtime; after 2 weeks can increase to 50 mg/day at bedtime
Amitriptyline (Elavil) [Show Less]